DHRM [Dehaier Medical Systems] 10-K:

[] [CERTIFICATION I, Ping Chen, certify that: (1) I have reviewed this Annual Report on Form 10-K of Dehaier Medical Systems Limited; (2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATION I, Zheng (Rita) Liu, certify that: (1) I have reviewed this Annual Report on Form 10-K of Dehaier Medical Systems Limited; (2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 2. The information contained in the Report fairly presents, in all material respects, the consolidated financial condition and results of operations of the Company. March 31, 2010 Ping Chen Chief Executive Officer] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 2. The information contained in the Report fairly presents, in all material respects, the consolidated financial condition and results of operations of the Company. March 31, 2010 Zheng (Rita) Liu Chief Financial Officer] [DEHAIER MEDICAL SYSTEMS LIMITED CHARTER OF THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS Purpose 1. The Audit Committee of Dehaier Medical Systems Limited (the “Company”) is appointed by the Board of Directors to assist the Board in fulfilling its oversight responsibilities by monitoring and reviewing: • The integrity of the Company’s financial reports and other financial information provided by]

BSPM [Biostar Pharmaceuticals,] 10-K: (Original Filing)

[FORM 10-K x For the fiscal year ended December31, 2009 OR o to For the transition period from 333-147363 BIOSTAR PHARMACEUTICALS, Maryland 20-5101287 (State or other jurisdiction oforporation or organization) (I.R.S. Employer Identification No.) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province The Peoples Republic of China 712046 (Zipde)] [Wu Quan Mountain Land Use Transferreement Party A: Villagemmittee of the Wu Quan Village, Jiang Cun Town, Huunty (Transferor) Party B: Shaanxi Aoxing Pharmaceutical (Transferee) I. Party A shall transfer the land use right to Party B of a land sized 9,000 Mou, east border at the center of Shi He, west border at the] [SECTION 302 OF THERBANES-OXLEY ACT OF 2002 I, Ronghua Wang, certify that: 1. I have reviewed this annual report on Form 10-K of Biostar Pharmaceuticals,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in] [SECTION 302 OF THERBANES-OXLEY ACT OF 2002 I, Elaine Zhao, certify that: 1. I have reviewed this annual report on Form 10-K of Biostar Pharmaceuticals,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in] [18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2)The informationntained in the Report fairly presents, inl material respects, the financialndition and result of operations of thempany at thetes and for the periods indicated. Ronghua Wang Chief Executive Officer March 31, 2010 ex32-1.htm] [18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2)The informationntained in the Report fairly presents, inl material respects, the financialndition and result of operations of thempany at thetes and for the periods indicated. Elaine Zhao Chief Financial Officer March 31, 2010 ex32-2.htm]

By | 2016-02-07T17:34:17+00:00 March 31st, 2010|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments

ALN [American Lorain] 8-K: (Original Filing)

[American Lorain Corporation Reports Results for the Fourth Quarter and Full Year, 2009 JUNAN COUNTY, China Fourth Quarter 2009 Highlights Revenue for the fourth quarter 2009 was $62.9 million, up 11.0% for the quarter. Operating income was $9.4 million, up 9.1% from the previous year. Net income was $6.3 million, a decrease of 1.5% versus prior year. EPS was $0.24] [____________________________ FORM 8-K CURRENT REPORT Date of Report (Date of Earliest Event Reported): March 29, 2010 AMERICAN LORAIN CORPORATION Delaware (State of Incorporation) 001-34449 (Commission File No.) 87-0430320 Shandong, China 276600 Beihuan Road (86) 539-7318818 £ £ £ £ Item 2.02. Results of Operations and Financial Condition.]

BSPM [Biostar Pharmaceuticals,] 10-K: FORM 10-K x For the fiscal year ended

[FORM 10-K x For the fiscal year ended December31, 2009 OR o to For the transition period from 333-147363 BIOSTAR PHARMACEUTICALS, Maryland 20-5101287 (State or other jurisdiction oforporation or organization) (I.R.S. Employer Identification No.) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province The Peoples Republic of China 712046 (Zipde)] [Wu Quan Mountain Land Use Transferreement Party A: Villagemmittee of the Wu Quan Village, Jiang Cun Town, Huunty (Transferor) Party B: Shaanxi Aoxing Pharmaceutical (Transferee) I. Party A shall transfer the land use right to Party B of a land sized 9,000 Mou, east border at the center of Shi He, west border at the] [SECTION 302 OF THERBANES-OXLEY ACT OF 2002 I, Ronghua Wang, certify that: 1. I have reviewed this annual report on Form 10-K of Biostar Pharmaceuticals,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in] [SECTION 302 OF THERBANES-OXLEY ACT OF 2002 I, Elaine Zhao, certify that: 1. I have reviewed this annual report on Form 10-K of Biostar Pharmaceuticals,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in] [18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2)The informationntained in the Report fairly presents, inl material respects, the financialndition and result of operations of thempany at thetes and for the periods indicated. Ronghua Wang Chief Executive Officer March 31, 2010 ex32-1.htm] [18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2)The informationntained in the Report fairly presents, inl material respects, the financialndition and result of operations of thempany at thetes and for the periods indicated. Elaine Zhao Chief Financial Officer March 31, 2010 ex32-2.htm]

By | 2016-02-07T17:35:10+00:00 March 31st, 2010|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments

ALN [American Lorain] 8-K: American Lorain Corporation Reports Results for the Fourth

[American Lorain Corporation Reports Results for the Fourth Quarter and Full Year, 2009 JUNAN COUNTY, China Fourth Quarter 2009 Highlights Revenue for the fourth quarter 2009 was $62.9 million, up 11.0% for the quarter. Operating income was $9.4 million, up 9.1% from the previous year. Net income was $6.3 million, a decrease of 1.5% versus prior year. EPS was $0.24] [____________________________ FORM 8-K CURRENT REPORT Date of Report (Date of Earliest Event Reported): March 29, 2010 AMERICAN LORAIN CORPORATION Delaware (State of Incorporation) 001-34449 (Commission File No.) 87-0430320 Shandong, China 276600 Beihuan Road (86) 539-7318818 £ £ £ £ Item 2.02. Results of Operations and Financial Condition.]

KNDI [Kandi Technologies] 10-K: (Original Filing)

[TABLE OF CONTENTS PART I Item 1. Business. 1-4] [EX-23.1 2 v179305_ex23-1.htm] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM To the Board of Directors of Kandi Technologies, Corp. WEINBERG & COMPANY, P.A. Certified Public Accountants Boca Raton, Florida March 31, 2010 EX-23.2 4 v179305_ex23-2.htm] [I, Hu Xiaoming, certify that: 1. I have reviewed this annual report on Form 10-K of Kandi Technologies, Corp. 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made,] [I, Zhu Xiaoying, certify that: 1. I have reviewed this annual report on Form 10-K of Kandi Technologies, Corp. 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made,] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Hu Xiaoming President and Chief Executive Officer Zhu Xiaoying Chief Financial Officer March 31, 2010 EX-32.1 7 v179305_ex32-1.htm]

DL [China Distance Education] 20-F: (Original Filing)

[Title of each class Name of each exchange on which registered American Depositary Shares, each representing four ordinary shares, par value $0.0001 per share None None Indicate the number of outstanding shares of each of the issuer’s classes of capital or common stock as of the close of the period covered by the annual report: 138,765,685 ordinary shares ¨ x] [Certification by the Chief Executive Officer I, Zhengdong Zhu, certify that: 1. I have reviewed this annual report on Form 20-F of China Distance Education Holdings Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [Certification by the Chief Financial Officer I, Ping Wei, certify that: 1. I have reviewed this annual report on Form 20-F of China Distance Education Holdings Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [Certification by the Chief Executive Officer Zhengdong Zhu Chief Executive Officer] [Certification by the Chief Financial Officer Ping Wei Chief Financial Officer] [Consent of Independent Registered Public Accounting Firm We consent to the incorporation by reference in the Registration Statement No. 333-157129 on Form S-8 of our reports dated March 30, 2010, relating to the consolidated financial statements of China Distance Education Holdings Limited, its subsidiaries and its variable interest entity (collectively, the “Group”) as of and for the year ended September] [Consent of Independent Registered Public Accounting Firm We consent to the incorporation by reference in the Registration Statement (Form S-8 No. 333-157129) pertaining to the China Distance Education Holdings Limited Share Incentive Plan and the China Distance Education Holdings Limited 2008 Performance Incentive Plan of our report dated December 10, 2008, with respect to the consolidated financial statements of China] [March 30, 2010 100 F. Street, N.E. Ladies and Gentlemen: EX-15.3 8 dex153.htm LETTER OF ERNST & YOUNG HUA MING TO SEC REGARDING THE DISCLOSURE IN ITEM 16F.] [March 30, 2010 Company China Distance Education Holdings Limited (the “ 18th Floor, Xueyuan International Tower 1 Zhichun Road, Haidian District Beijing 100083, People’s Republic of China Ladies and Gentlemen: Sincerely yours, Jingtian & Gongcheng EX-15.4 9 dex154.htm CONSENT OF JINGTIAN & GONGCHENG.] [March 30, 2010 China Distance Education Holdings Limited 18/F, Xueyuan International Tower No. 1 Zhichun Road, Haidian District Beijing, China 100083 Subject: WRITTEN CONSENT OF AMERICAN APPRAISAL CHINA LIMITED Yours faithfully, AMERICAN APPRAISAL CHINA LIMITED EX-15.5 10 dex155.htm CONSENT OF AMERICAN APPRAISAL.]

By | 2016-03-26T00:26:35+00:00 March 31st, 2010|Categories: Chinese Stocks, DL, SEC Original|Tags: , , , , , |0 Comments
Skip to toolbar